Literature DB >> 20381620

Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats.

Angelo C Lepore1, Christopher Tolmie, John O'Donnell, Megan C Wright, Christine Dejea, Britta Rauck, Ahmet Hoke, Anthony R Ignagni, Raymond P Onders, Nicholas J Maragakis.   

Abstract

In amyotrophic lateral sclerosis (ALS), the exogenous temporal triggers that result in initial motor neuron death are not understood. Overactivation and consequent accelerated loss of vulnerable motor neurons is one theory of disease initiation. The vulnerability of motor neurons in response to chronic peripheral nerve hyperstimulation was tested in the SOD1(G93A) rat model of ALS. A novel in vivo technique for peripheral phrenic nerve stimulation was developed via intra-diaphragm muscle electrode implantation at the phrenic motor endpoint. Chronic bilateral phrenic nerve hyperstimulation in SOD1(G93A) rats accelerated disease progression, including shortened lifespan, hastened motor neuron loss and increased denervation at diaphragm neuromuscular junctions. Hyperstimulation also resulted in focal decline in adjacent forelimb function. These results show that peripheral phrenic nerve hyperstimulation accelerates cell death of vulnerable spinal motor neurons, modifies both temporal and anatomical onset of disease, and leads to involvement of disease in adjacent anatomical regions in this ALS model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381620      PMCID: PMC2910141          DOI: 10.1016/j.nbd.2010.03.021

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  44 in total

1.  Activity alters muscle reinnervation and terminal sprouting by reducing the number of Schwann cell pathways that grow to link synaptic sites.

Authors:  Flora M Love; Young-Jin Son; Wesley J Thompson
Journal:  J Neurobiol       Date:  2003-03

Review 2.  Occurrence of amyotrophic lateral sclerosis among Gulf War veterans.

Authors:  R D Horner; K G Kamins; J R Feussner; S C Grambow; J Hoff-Lindquist; Y Harati; H Mitsumoto; R Pascuzzi; P S Spencer; R Tim; D Howard; T C Smith; M A K Ryan; C J Coffman; E J Kasarskis
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

3.  Disease progression of human SOD1 (G93A) transgenic ALS model rats.

Authors:  Arifumi Matsumoto; Yohei Okada; Masanori Nakamichi; Masaya Nakamura; Yoshiaki Toyama; Gen Sobue; Makiko Nagai; Masashi Aoki; Yasuto Itoyama; Hideyuki Okano
Journal:  J Neurosci Res       Date:  2006-01       Impact factor: 4.164

4.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Motor neuron disease after electric injury.

Authors:  H Jafari; P Couratier; W Camu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

6.  Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

Authors:  David S Howland; Jian Liu; Yijin She; Beth Goad; Nicholas J Maragakis; Benjamin Kim; Jamie Erickson; John Kulik; Lisa DeVito; George Psaltis; Louis J DeGennaro; Don W Cleveland; Jeffrey D Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

7.  Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis.

Authors:  Ilias G Kirkinezos; Dayami Hernandez; Walter G Bradley; Carlos T Moraes
Journal:  Ann Neurol       Date:  2003-06       Impact factor: 10.422

8.  Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.

Authors:  Jasna Kriz; Minh Dang Nguyen; Jean-Pierre Julien
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

9.  Minocycline delays disease onset and mortality in a transgenic model of ALS.

Authors:  Ludo Van Den Bosch; Petra Tilkin; Griet Lemmens; Wim Robberecht
Journal:  Neuroreport       Date:  2002-06-12       Impact factor: 1.837

10.  Altered reaction of facial motoneurons to axonal damage in the presymptomatic phase of a murine model of familial amyotrophic lateral sclerosis.

Authors:  R Mariotti; L Cristino; C Bressan; S Boscolo; M Bentivoglio
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

View more
  16 in total

1.  Functional and morphological assessment of diaphragm innervation by phrenic motor neurons.

Authors:  Melanie Martin; Ke Li; Megan C Wright; Angelo C Lepore
Journal:  J Vis Exp       Date:  2015-05-25       Impact factor: 1.355

2.  A hydrogel engineered to deliver minocycline locally to the injured cervical spinal cord protects respiratory neural circuitry and preserves diaphragm function.

Authors:  Biswarup Ghosh; Jia Nong; Zhicheng Wang; Mark W Urban; Nicolette M Heinsinger; Victoria A Trovillion; Megan C Wright; Angelo C Lepore; Yinghui Zhong
Journal:  Neurobiol Dis       Date:  2019-04-25       Impact factor: 5.996

3.  Structural and thermodynamic effects of post-translational modifications in mutant and wild type Cu, Zn superoxide dismutase.

Authors:  Elizabeth A Proctor; Feng Ding; Nikolay V Dokholyan
Journal:  J Mol Biol       Date:  2011-03-23       Impact factor: 5.469

Review 4.  Genetic rodent models of amyotrophic lateral sclerosis.

Authors:  L Van Den Bosch
Journal:  J Biomed Biotechnol       Date:  2011-01-02

5.  Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.

Authors:  Ke Li; Elham Javed; Tamara J Hala; Daniel Sannie; Kathleen A Regan; Nicholas J Maragakis; Megan C Wright; David J Poulsen; Angelo C Lepore
Journal:  Mol Ther       Date:  2014-12-10       Impact factor: 11.454

6.  Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.

Authors:  Nicole L Nichols; Irawan Satriotomo; Daniel J Harrigan; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2015-08-16       Impact factor: 5.330

7.  Overexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury.

Authors:  Ke Li; Charles Nicaise; Daniel Sannie; Tamara J Hala; Elham Javed; Jessica L Parker; Rajarshi Putatunda; Kathleen A Regan; Valérie Suain; Jean-Pierre Brion; Fred Rhoderick; Megan C Wright; David J Poulsen; Angelo C Lepore
Journal:  J Neurosci       Date:  2014-05-28       Impact factor: 6.167

8.  Effect of intra-cisternal application of kainic acid on the spinal cord and locomotor activity in rats.

Authors:  Nilesh K Mitra; Tiffanie E W Goh; Thalisha Bala Krishnan; Vishna D Nadarajah; Arun K Vasavaraj; Tomoko Soga
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

9.  Local BDNF Delivery to the Injured Cervical Spinal Cord using an Engineered Hydrogel Enhances Diaphragmatic Respiratory Function.

Authors:  Biswarup Ghosh; Zhicheng Wang; Jia Nong; Mark W Urban; Zhiling Zhang; Victoria A Trovillion; Megan C Wright; Yinghui Zhong; Angelo C Lepore
Journal:  J Neurosci       Date:  2018-06-11       Impact factor: 6.167

10.  The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression.

Authors:  Natasa Jokic; Ping K Yip; Adina Michael-Titus; John V Priestley; Andrea Malaspina
Journal:  BMC Genomics       Date:  2010-11-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.